Category: Sin categoría

EFSA sets a provisional safe level of about 2 mg of CBD per day. What changes for hemp manufacturers, distributors and brands across the EU.

Spain schedules HHC, THC-O and H4-CBD, and the UN has controlled HHC since December 2025. What it changes for hemp and CBD businesses across Europe.

AEMPS registers Spain’s first two standardised cannabis preparations. Royal Decree 903/2025 moves from paper to hospital pharmacy supply.

Germany is finalising a law to ban telemedicine and mail-order medical cannabis, the channel that drove its imports up 176% in 2025.

The EU is finalising its biggest pharma reform in 20 years: 11-year exclusivity, a regulatory sandbox and new EU-GMP rules for medical cannabis.

France submits its medical cannabis decree to the Conseil d’Etat. Generalisation opens a European import market, with patient access expected in 2027.

Median price per gram falls 31% in Germany as potency rises and imports slow 15%. What it means for the European cannabis industry.

EFSA sets a provisional safe CBD level (~2 mg/day) as a novel food: what it now demands from Europe’s cannabidiol industry and what changes.

Royal Decree 903/2025 is now operational: the standardized preparations registry is live and the first compounded formulation is typified. What it means for producers, labs and distribution.

The EU drugs agency EUDA puts the number of adults who used cannabis last year at 25 million and warns of resin averaging 24.6% THC. What it means for the industry.